Sirnaomics Announces 2023 Annual Results : vimarsana.com

Focuses on the Consolidation for Leading Projects
Accelerates Clinical Trials for Core Products STP705, STP707 and STP122G
HONG KONG, Germantown, Md. and SUZHOU, China, March 28, 2024 /PRNewswire/...

Related Keywords

United States , China , Guangzhou , Guangdong , Suzhou , Jiangsu , Patrick Lu , Group Galahead , Prnewswire Sirnaomics Ltd , Sirnaomics Ltd , Drug Administration , Leading Projects , Clinical Trials , Core Products , Investigational New Drug Application , Response Evaluation Criteria , Guangzhou Fill , Executive Director , Chief Executive Officerof Sirnaomics , Stock Code , Markets ,